Peer Review History
| Original SubmissionMarch 17, 2025 |
|---|
|
Dear Dr. Feng, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Xing-Xiong An, M.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: I Don't Know Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: This paper looks at how people in Chengdu, China, see the risk of getting the flu and how much social support they have after COVID-19 restrictions were lifted. It's an important topic, but the paper needs several improvements before it can be published. Major Issues: 1. Sampling Problems: - Most of the people in the study were young, female, and healthcare workers. This doesn’t represent the general public. - Suggestion: Clearly state this as a limitation and explain how it might affect the results. 2. Risk Perception Tool Not Fully Explained: - The risk perception survey was created by the researchers but there’s not enough detail about how it was tested or validated. - Suggestion: Either explain how the tool was tested or use a survey tool that’s already been proven to work well. 3. Weak Correlation: - The link between social support and risk perception is very weak. The authors make too much of this small connection. - Suggestion: Be more careful in describing what this small effect means, and mention other possible explanations. 4. Missing Theory: - There’s no clear explanation or model showing how social support and risk perception are supposed to be connected. - Suggestion: Use a well-known health behavior theory to help explain the results. 5. Too Focused on p-values: - The authors focus too much on whether something is statistically significant, without showing if it really matters in the real world. - Suggestion: Talk more about whether the findings are meaningful, not just if the p-value is less than 0.05. Minor Issues: 1. English and Grammar: - Some parts are hard to read due to grammar or awkward wording. - Suggestion: Have someone fluent in English edit the paper. 2. Missing or Unclear Tables: - Tables are mentioned but not included properly. - Suggestion: Make sure all tables are formatted and included correctly. 3. Ethics Approval Numbers: - Two different ethics approval numbers are listed. - Suggestion: Fix this and use the correct one throughout. 4. Duplicate References: - Some references are repeated. - Suggestion: Clean up the reference list. Reviewer #2: This is a well-structured and timely study addressing the interplay between social support and risk perception of influenza in the unique post-pandemic setting of Chengdu, China. The study design, ethical approval, sample size (n=708), and statistical methodology are appropriate. The results offer novel insights that could guide public health policies focused on risk communication and behavioral interventions. Strengths: Large and Diverse Sample: With over 700 participants from various demographics and occupations, the findings carry significant internal validity. Validated Scales: The use of SSRS and a well-constructed RPS strengthens the methodological rigor. Relevant Context: The post-COVID-19 recovery setting offers valuable information on evolving public health perceptions. Ethical Compliance: IRB approval and informed consent were clearly described. Areas for Minor Revision: Clarify Scale Interpretation: A more detailed explanation of how to interpret the SSRS and RPS scores would help readers less familiar with these tools. Sampling Limitation: While limitations are acknowledged, further elaboration on the impact of convenience sampling and gender imbalance (85% female) on generalizability is warranted. Discussion Depth: The inverse correlation between social support and risk perception is intriguing but somewhat counterintuitive. The authors suggest cultural self-reliance as one explanation—this could be expanded with references or theoretical support. Figures/Tables: Consider adding a visual summary of the correlation analysis (e.g., heatmap or matrix) to complement the text. English Editing: Overall very good, but a few grammatical tweaks would improve readability (e.g., rephrasing "suboptimal utilization of social support" to "limited utilization" or similar alternatives). Reviewer #3: General Comments: Overall, the authors need to expand on their methodology and how the scores were calculated. The study has multiple design flaws, see specific comments below. Specific Comments: Methods: 1. The authors mention using convenient sampling but fail to report where the sample was drawn from. 2. Who is the population with access to the questionnaire star platform? 3. Does including non-adults (age criteria 12-70) affect / result in increase variability in the risk perception scale results? 4. Was the risk perception scale validated for children and adults? Results: 1. Table 1: 65.7% were < 25, 28% are 25-40, and 6.5 % > 40; do the author thinks the skewed results favoring your participants could have skewed the results. Since study was planned for age 12-70. 2. I am not sure how the risk score was calculated (the percentage). 3. Same comment for the social support score. Limitation: 1. Authors mention over representation of healthcare professionals but it seems to me like we are mainly comparing healthcare professionals to students (two major groups) which could be misleading are the two groups have major differences in age, education, and life experiences. 2. All other groups lumped in others are a small percentage, raising concerns about the results. Minor comments: 1. Further details about the validation of the risk perception scale need to be added in addition to the reference. Reviewer #4: The introduction provides some epidemiological context, but it lacks a clear rationale for focusing on Chengdu. Why was this city selected? Was Chengdu more severely affected by influenza resurgence than others? Is it representative of a broader population, or does it have unique sociocultural traits relevant to risk perception and support systems? The use of convenience sampling introduces a significant selection bias, especially given the skewed age distribution reported (65.7% were under 25). This dramatically limits generalizability and raises concerns about the study’s ability to reflect the broader Chengdu population's perceptions. The sample also disproportionately includes healthcare workers (44.1%) and students (37.9%), suggesting recruitment was heavily tied to academic or medical institutions, which is not representative of the general community. Using a researcher-developed instrument for measuring risk perception—particularly when validated tools already exist—requires a comprehensive justification. While the authors cite high Cronbach’s alpha and content validity, these indicators alone are insufficient. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Elabbass Ali Abdelmahmuod Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Feng, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Xing-Xiong An, M.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #4: Yes ********** Reviewer #2: Suggestions for Minor Revision: Clarify Sampling Bias: The overrepresentation of healthcare workers and students may limit generalizability. Please elaborate more clearly in the discussion on how this may affect risk perception findings. Expand on Cultural Factors: The negative correlation between social support and risk perception is intriguing. A brief expansion on cultural or psychological interpretations would enrich the discussion. Minor Language Edits: Minor corrections are recommended for grammatical polishing. For example: "women 602" → should be "female: 602 (85.0%)" Replace "thesis writing" in author contributions with "manuscript preparation" for more appropriate academic terminology. Reviewer #4: The phrasing "we assessed dietary patterns" is broad and lacks scientific precision. It does not specify which dietary patterns were under investigation (e.g., Mediterranean, fast food-heavy, plant-based), nor does it clarify the health risks measured—whether these were physiological (e.g., BMI, blood pressure) or behavioral (e.g., physical inactivity). Manuscript does not describe whether any validated dietary assessment tools were used. For example, was a food frequency questionnaire (FFQ) utilized? If yes, was it culturally adapted and validated in the population of interest? Without this information, it is diffcult to judge the accuracy and reliability of the dietary data. Data may indicate certain unhealthy dietary patterns, the leap to concluding "significant risk of non-communicable diseases" is not supported by any inferential statistical analysis or longitudinal evidence. Cross-sectional data can suggest correlations but not causations or future health outcomes. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Dear Dr. Feng, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Xing-Xiong An, M.D. Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Thanks for submitting your revised paper to PLOS ONE. Your manuscript has now been assessed by our editorial team and previous peer experts, and I am pleased to inform you that your revised work has been approved by the reviewers. However, before I can recommend the final editorial decision to our journal office, some minor issues from Reviewer #4 need your attention. Please address them. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes ********** Reviewer #4: Although it is good manuscript and author has addressed past comments. In some of the area still minor work needed. Such as in abstract numbers are provided (e.g., median scores, percentages, p-values), there’s no interpretive glue connecting them. For instance, the sentence: “Median social support and risk perception scores were 37 (63.79%) and 36 (40.0%) respectively” lacks context — is 40% alarmingly low? Is 63.79% moderate or high? But overall this is acceptable. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
Social Support and Risk Perception of Influenza Among Chengdu Residents: A Cross-Sectional Study During Post-Pandemic Recovery PONE-D-25-07963R3 Dear Dr. Feng, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Xing-Xiong An, M.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Thanks for the authors' efforts to comprehensively improve your manuscript according to editor's and reviewers' comments. I am pleased to inform you that your paper can be accepted for publication now. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-07963R3 PLOS ONE Dear Dr. Feng, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Xing-Xiong An Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .